MedPAC Report Recommends Reduction in Medicare Part B Payments to 340B Hospitals


On March 15, 2016, the Medicare Payment Advisory Commission (MedPAC) released its latest report to Congress that included 340B Implications for Medicare Part B Drugs along with a quick fact sheet regarding the report. Key highlights, as they relate to 340B entities, include:

Below are some key issues regarding MedPAC’s recommendations, should they be adopted by Congress:

Given the current political environment in Washington and due to the upcoming election, many believe that it’s unlikely Congress would act on this specific recommendation until the election is over.


© Polsinelli PC, Polsinelli LLP in California
National Law Review, Volume VI, Number 81